Featured News
AIM Blog
Recognizing AIM’s January Advocate of the Month: Ben Woodworth
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
Press Release
Alzheimer’s Association Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments
The Alzheimer’s Association recognizes that the Centers for Medicare & Medicaid Services (CMS) has announced their conceptual approach to fulfill...
Press Release
Alzheimer’s Association Statement on Announcement of Rosalynn Carter’s Dementia Diagnosis
The Alzheimer’s Association expresses our deepest appreciation to former First Lady Rosalynn Carter and her family for sharing her diagnosis...
AIM Blog
Alzheimer’s Advocates Rally for CMS to “Fix This Mess” and Stop Blocking Access to Alzheimer’s Treatments
In communities across the nation, passionate Alzheimer’s advocates put on their purple, picked up their signs and rallied for access...
Press Release
Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab
CHICAGO, May 25, 2023 — The Alzheimer's Association and members of the Association's Early Stage Advisory Group submitted comments to...
Press Release
Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means
— Congressional Bipartisan Support for Individuals, Families and Treatment on Display — WASHINGTON, D.C., May 10, 2023 — Today, Tony...
Press Release
Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release
Strongest Alzheimer's Phase 3 data release to date Association underscores urgent call for CMS to stop blocking access to FDA-approved...